| 1. |
付朝伟, 徐飚, 詹思延, 等. 中国四城市综合医院神经内科患者抑郁、焦虑现况研究. 中华流行病学杂志, 2006, 27: 803-807.
|
| 2. |
Gandy M, Modi AC, Wagner JL, et al. Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force. Epilepsia Open, 2021, 6(1): 127-139.
|
| 3. |
Chu C. Association between epilepsy and risk of depression: a meta-analysis. Psychiatry Res. 2022;312: 114531.
|
| 4. |
Minjung Kim, Young-Soo Kim, Do-Hyung Kim, et al. Major depressive disorder in epilepsy clinics: a meta-analysis Epilepsy Behav, 2018, 84: 56-69.
|
| 5. |
Mendez MF, Doss RC, Taylor JL, et al. Depression in epilepsy: relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis, 1993, 181: 444-447.
|
| 6. |
Hermann BP. Psychopathology in epilepsy. Br J Psychiatry J Ment Sci, 1982, 141: 313-314.
|
| 7. |
Ettinger A, Reed M, Cramer J; Epilepsy Impact Project Group. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology, 2004, 63: 1008-1014.
|
| 8. |
Tellez-Zenteno JF, Patten SB, Jetté N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(10): 2336-2344.
|
| 9. |
Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia, 2000, 41(Suppl 2): 31–41.
|
| 10. |
Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs, 2002, 16: 291-302.
|
| 11. |
Yang YH, Yang MY, Shi QL, et al. Risk factors for depression in patients with epilepsy: a meta-analysis. Epilepsy Behav, 2020, 106: 107030.
|
| 12. |
Christensen J, Vestergaard M, Mortensen PB, et al. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol, 2007, 6(8): 693-698.
|
| 13. |
Thome-Souza MS, Kuczynski E, Valente KD. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav, 2007, 10: 417-425.
|
| 14. |
Hermann BP, Riel P. Interictal personality and behavioral traits in temporal lobe and generalized epilepsy. Cortex, 1981, 17: 125-128.
|
| 15. |
Swinkels WA, Kuyk J, van Dyck R, et al. Psychiatric comorbidity in epilepsy. Epilepsy Behav, 2005, 7: 37-50.
|
| 16. |
Josephson CB, Lowerison M, Vallerand I, et al. Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis. JAMA Neurol, 2017, 74(5): 533-539.
|
| 17. |
Lin H, Lin WH, Lin F, et al. Potential pleiotropic genes and shared biological pathways in epilepsy and depression based on GWAS summary statistics. Comput Intell Neurosci, 2022, 20: 6799285.
|
| 18. |
Rosso IM, Cintron CM, Steingard RJ, et al. Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry, 2005, 57: 21-26.
|
| 19. |
Richardson EJ, Griffith HR, Martin RC, et al. Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav, 2007, 10: 242-249.
|
| 20. |
D'Alessio L, Mesarosova L, Anink JJ, et al. Reduced expression of the glucocorticoid receptor in the hippocampus of patients with drug-resistant temporal lobe epilepsy and comorbid depression. Epilepsia, 2020, 61(8): 1595-1605.
|
| 21. |
Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem, 2013, 31: 761-777.
|
| 22. |
Maguire J, Salpekar JA. Stress, seizures, and hypothalamic–pituitary–adrenal axis targets for the treatment of epilepsy. Epilepsy Behav, 2013, 26: 352-362.
|
| 23. |
Toniolo S, Lorenzo FD, Bozzali M, et al. The impact of lacosamide on mood disorders in adult patients with epilepsy: a systematic review. Epilepsy Behav, 2020, 111: 107179.
|
| 24. |
Kerr MP, Mensah S, Besag F, et al. International League of Epilepsy Commission on the Neuropsychiatric Aspects of E. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia, 2011, 52(11): 2133-2138.
|
| 25. |
Mula M. Developments in depression in epilepsy: screening, diagnosis, and treatment. Expert Rev Neurother, 2019, 19(3): 269-276.
|
| 26. |
Tong X, An D, Lan L, et al. Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China. Epilepsy Behav, 2015, 47: 6-10.
|
| 27. |
Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia, 2013, 54(Suppl1): 3-12.
|
| 28. |
Liu HY, Potter MP, Woodworth KY, et al. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry, 2011, 50: 749-762.
|
| 29. |
Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic–clonic seizures. Neurology, 2005, 65: 1737-1743.
|
| 30. |
Mazza M, Della Marca G, Di Nicola M, et al. Oxcarbazepine improves mood in patients with epilepsy. Epilepsy Behav, 2007, 10: 397-401.
|
| 31. |
Andersohn F, Schade R, Willich SN, et al. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology, 2010, 75(4): 335.
|
| 32. |
Mula M, Brodie MJ, Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia, 2022, 63(2): 316-334.
|
| 33. |
Feng HX, Wang MX, Zhao HM, et al. Effect of cognitive behavioral intervention on anxiety, depression, and quality of life in patients with epilepsy. Am J Transl Res, 2022, 14(7): 5077-5087.
|
1/5
WeChat